Heart Test Laboratories, Inc. (HSCS)
Automate Your Wheel Strategy on HSCS
With Tiblio's Option Bot, you can configure your own wheel strategy including HSCS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HSCS
- Rev/Share 0.0
- Book/Share 1.812
- PB 0.0019
- Debt/Equity 0.0017
- CurrentRatio 0.9783
- ROIC -498.0242
- MktCap 3817793.0
- FreeCF/Share -4268.2206
- PFCF -0.0009
- PE -0.0014
- Debt/Assets 0.5237
- DivYield 0
- ROE -1.7483
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 5
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
Published: May 29, 2025 by: GlobeNewsWire
Sentiment: Neutral
Southlake, TX, May 29, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”)-powered medical technology company focused on transforming ECGs/EKGs to enable earlier detection of heart disease, today announced the signing of its first commercial customer for the MyoVista Insights™ platform: Westcliffe Health Innovations, based in the United Kingdom.
Read More
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson
Published: May 08, 2025 by: GlobeNewsWire
Sentiment: Neutral
Southlake, TX, May 08, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that it will host a live investor webinar on Wednesday, May 14, 2025, at 2:00 p.m. EDT | 11:00 a.m. PDT, featuring a presentation and Q&A session with CEO Andrew Simpson.
Read More
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board
Published: May 07, 2025 by: GlobeNewsWire
Sentiment: Neutral
Southlake, TX, May 07, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced the appointment of Dr. Girish Nadkarni, MD, Dr. Joshua Lampert, MD, and Dr. Akhil Vaid, MBBS, to its Scientific Advisory Board. These appointments underscore HeartSciences' commitment to advancing and transforming data-driven AI-ECG technology.
Read More
HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications
Published: March 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
Southlake, TX, March 10, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced today that it has engaged Integrous Communications, a premier investor relations firm, to enhance communication channels with investors and the investment community. Under the expert guidance of Integrous Communications, HeartSciences will embark on a comprehensive investor relations program, benefiting from Integrous Communications' proven track record in collaborating with leading medical companies to develop and execute an effective investor relations program.
Read More
About Heart Test Laboratories, Inc. (HSCS)
- IPO Date 2022-06-16
- Website https://heartsciences.com
- Industry Medical - Devices
- CEO Mr. Andrew Simpson
- Employees 15